Sabby Healthcare Master Fund, Ltd. just filed a "Statement of acquisition of beneficial ownership", which is also known as a 13G. In the filing, it appears as though Sabby Healthcare Master Fund, Ltd. claims to own 844,192 shares. This represents 4.82% of Biocept.
Please note that typos are common in SEC filings. Please verify the information reported above before acting on it.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!